#METABOLOMICS WORKBENCH Linyan_20231215_005254 DATATRACK_ID:4522 STUDY_ID:ST003013 ANALYSIS_ID:AN004946 PROJECT_ID:PR001876
VERSION             	1
CREATED_ON             	December 18, 2023, 10:28 am
#PROJECT
PR:PROJECT_TITLE                 	NMR- and MS-based omics reveal characteristic metabolome atlas and optimize
PR:PROJECT_TITLE                 	biofluid earlydiagnostic biomarkers for esophageal squamous cell carcinoma
PR:PROJECT_SUMMARY               	Metabolic changes precede malignant histology. However, it remains unclear
PR:PROJECT_SUMMARY               	whether detectable characteristic metabolome exists in esophageal squamous cell
PR:PROJECT_SUMMARY               	carcinoma (ESCC) tissues and biofluids for early diagnosis. We conducted NMR-
PR:PROJECT_SUMMARY               	and MS-based metabolomics on 1,153 matched ESCC tissues, normal mucosae, pre-
PR:PROJECT_SUMMARY               	and one-week post-operative sera and urines from 560 participants across three
PR:PROJECT_SUMMARY               	hospitals, with machine learning, logistic regression and WGCNA. Aberrations in
PR:PROJECT_SUMMARY               	'alanine, aspartate and glutamate metabolism' proved to be prevalent throughout
PR:PROJECT_SUMMARY               	the ESCC evolution, and were reflected in 16 serum and 10 urine metabolic
PR:PROJECT_SUMMARY               	signatures that were consistently identified by NMR and MS in both discovery and
PR:PROJECT_SUMMARY               	validation sets. NMR-based simplified panels of any five serum or urine
PR:PROJECT_SUMMARY               	metabolites outperformed clinical serological tumor markers (AUC = 0.984 and
PR:PROJECT_SUMMARY               	0.930, respectively), and were effective in distinguishing early-stage ESCC in
PR:PROJECT_SUMMARY               	test set (serum accuracy = 0.994, urine accuracy = 0.879). Collectively,
PR:PROJECT_SUMMARY               	NMR-based biofluid screening can reveal characteristic metabolic events of ESCC
PR:PROJECT_SUMMARY               	and be feasible for early detection (ChiCTR2300073613).
PR:INSTITUTE                     	Radiology Department, Second Affiliated Hospital, Shantou University Medical
PR:INSTITUTE                     	College, Shantou
PR:LAST_NAME                     	Lin
PR:FIRST_NAME                    	Yan
PR:ADDRESS                       	No. 69, Dongxia North Road, Shantou, Guangdong, China
PR:EMAIL                         	994809889@qq.com
PR:PHONE                         	+86 18823992148
#STUDY
ST:STUDY_TITLE                   	NMR- and MS-based omics reveal characteristic metabolome atlas and optimize
ST:STUDY_TITLE                   	biofluid earlydiagnostic biomarkers for esophageal squamous cell carcinoma
ST:STUDY_TITLE                   	(part-Ⅱ)
ST:STUDY_SUMMARY                 	Metabolic changes precede malignant histology. However, it remains unclear
ST:STUDY_SUMMARY                 	whether detectable characteristic metabolome exists in esophageal squamous cell
ST:STUDY_SUMMARY                 	carcinoma (ESCC) tissues and biofluids for early diagnosis. We conducted NMR-
ST:STUDY_SUMMARY                 	and MS-based metabolomics on 1,153 matched ESCC tissues, normal mucosae, pre-
ST:STUDY_SUMMARY                 	and one-week post-operative sera and urines from 560 participants across three
ST:STUDY_SUMMARY                 	hospitals, with machine learning, logistic regression and WGCNA. Aberrations in
ST:STUDY_SUMMARY                 	'alanine, aspartate and glutamate metabolism' proved to be prevalent throughout
ST:STUDY_SUMMARY                 	the ESCC evolution, and were reflected in 16 serum and 10 urine metabolic
ST:STUDY_SUMMARY                 	signatures that were consistently identified by NMR and MS in both discovery and
ST:STUDY_SUMMARY                 	validation sets. NMR-based simplified panels of any five serum or urine
ST:STUDY_SUMMARY                 	metabolites outperformed clinical serological tumor markers (AUC = 0.984 and
ST:STUDY_SUMMARY                 	0.930, respectively), and were effective in distinguishing early-stage ESCC in
ST:STUDY_SUMMARY                 	test set (serum accuracy = 0.994, urine accuracy = 0.879). Collectively,
ST:STUDY_SUMMARY                 	NMR-based biofluid screening can reveal characteristic metabolic events of ESCC
ST:STUDY_SUMMARY                 	and be feasible for early detection (ChiCTR2300073613).
ST:INSTITUTE                     	Radiology Department, Second Affiliated Hospital, Shantou University Medical
ST:INSTITUTE                     	College, Shantou
ST:LAST_NAME                     	Lin
ST:FIRST_NAME                    	Yan
ST:ADDRESS                       	No. 69, Dongxia North Road, Shantou, Guangdong, China
ST:EMAIL                         	994809889@qq.com
ST:PHONE                         	+86 18823992148
#SUBJECT
SU:SUBJECT_TYPE                  	Human
SU:SUBJECT_SPECIES               	Homo sapiens
SU:TAXONOMY_ID                   	9606
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#1	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.1.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#2	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.2.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#3	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.3.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#4	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.4.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#5	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.5.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#6	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.6.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#7	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.7.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#8	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.8.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#9	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.9.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#10	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.10.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#11	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.11.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#12	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.12.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#13	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.13.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#14	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.14.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#15	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.15.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#16	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.16.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#17	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.17.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#18	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.18.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#19	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.19.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#20	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.20.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#21	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.21.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#22	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.22.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#23	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.23.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#24	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.24.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#25	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.25.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#26	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.26.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#27	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.27.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#28	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.28.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#29	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.29.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#30	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.30.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#31	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.31.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#32	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.32.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#33	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.33.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#34	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.34.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#35	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.35.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#36	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.36.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#37	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.37.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#38	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.38.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#39	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.39.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#40	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.40.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#41	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.41.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#42	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.42.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#43	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.43.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#44	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.44.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#45	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.45.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#46	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.46.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#47	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.47.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#48	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.48.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#49	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.49.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#50	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.50.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#51	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.51.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#52	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.52.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#53	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.53.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#54	Fator:Pre-operation	RAW_FILE_NAME=Raw_ESCC Serum.54.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#55	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.55.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#56	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.56.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#57	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.57.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#58	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.58.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#59	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.59.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#60	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.60.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#61	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.61.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#62	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.62.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#63	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.63.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#64	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.64.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#65	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.65.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#66	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.66.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#67	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.67.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#68	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.68.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#69	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.69.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#70	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.70.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#71	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.71.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#72	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.72.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#73	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.73.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#74	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.74.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#75	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.75.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#76	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.76.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#77	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.77.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#78	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.78.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#79	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.79.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#80	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.80.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#81	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.81.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#82	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.82.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#83	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.83.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#84	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.84.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#85	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.85.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#86	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.86.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#87	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.87.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#88	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.88.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#89	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.89.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#90	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.90.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#91	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.91.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#92	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.92.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#93	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.93.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#94	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.94.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#95	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.95.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#96	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.96.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#97	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.97.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#98	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.98.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#99	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.99.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#100	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.100.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#101	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.101.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#102	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.102.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#103	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.103.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#104	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.104.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#105	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.105.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#106	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.106.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#107	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.107.fid
SUBJECT_SAMPLE_FACTORS           	-	EC Sera-20220608.1.fid#108	Fator:Post-operation	RAW_FILE_NAME=Raw_ESCC Serum.108.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.1.fid#131	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.1.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.2.fid#132	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.2.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.3.fid#133	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.3.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.4.fid#134	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.4.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.5.fid#135	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.5.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.6.fid#136	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.6.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.7.fid#137	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.7.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.8.fid#138	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.8.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.9.fid#139	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.9.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.10.fid#140	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.10.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.11.fid#141	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.11.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.12.fid#142	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.12.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.13.fid#143	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.13.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.14.fid#144	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.14.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.15.fid#145	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.15.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.16.fid#146	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.16.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.17.fid#147	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.17.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.18.fid#148	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.18.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.19.fid#149	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.19.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.20.fid#150	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.20.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.21.fid#151	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.21.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.22.fid#152	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.22.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.23.fid#153	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.23.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.24.fid#154	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.24.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.25.fid#155	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.25.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.26.fid#156	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.26.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.27.fid#157	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.27.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.28.fid#158	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.28.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.29.fid#159	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.29.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.30.fid#160	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.30.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.31.fid#161	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.31.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.32.fid#162	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.32.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.33.fid#163	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.33.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.34.fid#164	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.34.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.35.fid#165	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.35.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.36.fid#166	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.36.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.37.fid#167	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.37.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.38.fid#168	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.38.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.39.fid#169	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.39.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.40.fid#170	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.40.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.41.fid#171	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.41.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.42.fid#172	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.42.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.43.fid#173	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.43.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.44.fid#174	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.44.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.45.fid#175	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.45.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.46.fid#176	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.46.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.47.fid#177	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.47.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.48.fid#178	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.48.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.49.fid#179	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.49.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.50.fid#180	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.50.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.51.fid#181	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.51.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.52.fid#182	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.52.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.53.fid#183	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.53.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.54.fid#184	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.54.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.55.fid#185	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.55.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.56.fid#186	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.56.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.57.fid#187	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.57.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.58.fid#188	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.58.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.59.fid#189	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.59.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.60.fid#190	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.60.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.61.fid#191	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.61.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.62.fid#192	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.62.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.63.fid#193	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.63.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.64.fid#194	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.64.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.65.fid#195	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.65.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.66.fid#196	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.66.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.67.fid#197	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.67.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.68.fid#198	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.68.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.69.fid#199	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.69.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.70.fid#200	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.70.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.71.fid#201	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.71.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.72.fid#202	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.72.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.73.fid#203	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.73.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.74.fid#204	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.74.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.75.fid#205	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.75.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.76.fid#206	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.76.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.77.fid#207	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.77.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.78.fid#208	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.78.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.79.fid#209	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.79.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.80.fid#210	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.80.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.81.fid#211	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.81.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.82.fid#212	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.82.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.83.fid#213	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.83.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.84.fid#214	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.84.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.85.fid#215	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.85.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.86.fid#216	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.86.fid
SUBJECT_SAMPLE_FACTORS           	-	HC2.87.fid#217	Fator:HC	RAW_FILE_NAME=Raw_HC Sera.87.fid
#COLLECTION
CO:COLLECTION_SUMMARY            	Serum samples: Fasting blood was drawn into additive-free vacuum blood
CO:COLLECTION_SUMMARY            	collection tubes, taking care to avoid hemolysis. Samples were left to clot
CO:COLLECTION_SUMMARY            	naturally for 30 minutes and then centrifuged for 10 minutes at 3000 rpm and
CO:COLLECTION_SUMMARY            	4°C. Following centrifugation, the serum supernatant was aliquoted into storage
CO:COLLECTION_SUMMARY            	tubes, promptly frozen in liquid nitrogen, and stored at −80°C until
CO:COLLECTION_SUMMARY            	analysis.
CO:COLLECTION_PROTOCOL_FILENAME  	NMR_Serum_collection_uploaded.pdf
CO:SAMPLE_TYPE                   	Blood (serum)
CO:STORAGE_CONDITIONS            	-80℃
#TREATMENT
TR:TREATMENT_SUMMARY             	None
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	Serum preparation: A total of 400 μL of serum was combined with 200 μL of
SP:SAMPLEPREP_SUMMARY            	PBS/D2O buffer (pH 7.4, containing 0.9% NaCl) using vortexing to ensure thorough
SP:SAMPLEPREP_SUMMARY            	mixing. The resulting mixture was then centrifuged at 10,000 rpm for 10 min at
SP:SAMPLEPREP_SUMMARY            	4°C. Finally, the supernatant, which amounted to 550 μL, was carefully
SP:SAMPLEPREP_SUMMARY            	transferred into a 5 mm NMR tube for further analysis.
SP:SAMPLEPREP_PROTOCOL_FILENAME  	Serum_preparation_uploaded.pdf
SP:PROCESSING_STORAGE_CONDITIONS 	4℃
SP:EXTRACT_STORAGE               	4℃
#ANALYSIS
AN:ANALYSIS_TYPE                 	NMR
#NMR
NM:INSTRUMENT_NAME               	6000 MHz Bruker Avance III
NM:INSTRUMENT_TYPE               	FT-NMR
NM:NMR_EXPERIMENT_TYPE           	1D-1H
NM:SPECTROMETER_FREQUENCY        	600 MHz
NM:NMR_SOLVENT                   	H2O+D2O
NM:NMR_RESULTS_FILE               	ST003013_AN004946_Results.txt	UNITS:gauss
#END